Proteomics International Laboratories has announced a partnership with medical device sales agency Growth Medics to expand the reach of its PromarkerD predictive test for diabetic kidney disease within the EU.
The collaboration is aimed at identifying and selecting EU alliance partners to enhance the distribution of PromarkerD.
Growth Medics will help identify, recruit and manage new partners and customers across Europe for Proteomics.
The engagement is focused on digital marketing efforts to increase the visibility and adoption of PromarkerD.
